(Q34337134)

1 August 2017

title

Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

2

Birke Bartosch

0 references

François-Loic Cosset

9

object named as

François-Loïc Cosset

0 references

Robert H. Purcell

10

object named as

Robert H Purcell

1 reference

1 August 2017

Mei-ying W Yu

1

1 reference

1 August 2017

Pei Zhang

3

1 reference

1 August 2017

Zheng-ping Guo

4

1 reference

1 August 2017

Paula M Renzi

5

1 reference

1 August 2017

Li-Ming Shen

6

1 reference

1 August 2017

Christelle Granier

7

1 reference

1 August 2017

Stephen M Feinstone

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

10 May 2004

1 reference

Proceedings of the National Academy of Sciences of the United States of America

1 August 2017

published in

1 reference

1 August 2017

volume

101

1 reference

1 August 2017

issue

20

1 reference

1 August 2017

page(s)

7705-7710

1 reference

In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Gammagard and reported hepatitis C virus episodes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Vaccination of chimpanzees against infection by the hepatitis C virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Partitioning of hepatitis C virus during Cohn-Oncley fractionation of plasma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. A Veterans Administration cooperative study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

A clinical and laboratory evaluation of immune serum globulin from donors with a history of hepatitis: attempted prevention of post-transfusion hepatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins

6 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Hepatitis C transmission associated with intravenous immunoglobulins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Detection and characterization of hepatitis C virus RNA in immune globulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Effect of immune globulin on the prevention of experimental hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Calibration of HCV working reagents for NAT assays against the HCV international standard. The Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0402458101

Outbreak of hepatitis C associated with intravenous immunoglobulin administration--United States, October 1993-June 1994.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=419670

Anti-HCV screening and plasma fractionation: the case against

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15136748

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0402458101

1 reference

1 August 2017

0 references

1 reference

1 August 2017

1 reference